Full Title: Emerging Pharmaceutical Markets: Growth opportunities, changing healthcare dynamics and regulatory trends The growth of emerging pharmaceutical markets remains impressively buoyant, having attained a 14.7% value increase over the 2005-06 period, a substantially greater rate than those witnessed within the developed markets of the EU and US. Although emergent markets proffer access to sizeable patient populations, significant barriers to entry continue to exist. For Western players, successful entry is contingent upon a comprehensive understanding of market dynamics, including differentiated growth prospects, sociopolitical structures and local market environments. Sustainable success can be derived from maintaining an acute awareness and timely exploitation of opportunities and threats that arise from healthcare financing systems, epidemiology and therapeutic forecasts, pricing and reimbursement policies, licensing sales trends, IP protection and leading player dynamics. Emerging Pharmaceutical Markets is a new report published by Business Insights, examining the external, regulatory and competitive environments of emergent markets in 24 countries across Asia, Central and Eastern Europe, and Latin America. The impact of licensing laws and reforms upon market penetration potential within these countries is assessed, and the trends that influence market opportunities are profiled. This report will also provide detailed analyses and forecasts to establish the future direction of emergent markets, and identify the key strategies necessary in securing successful market entry and sustainable growth. Use this report to evaluate the performance of pharma sales in 24 emergent countries, identify the key external and regulatory factors shaping these markets and assess the strategies of leading competitors... Pages: 270+ Table of Contents Download TOC in PDF
|
